| Literature DB >> 32654691 |
Abstract
Chronic lung disease is a complication of primary antibody deficiency (PAD) associated with significant morbidity and mortality. Manifestations of lung disease in PAD are numerous. Thoughtful application of diagnostic approaches is imperative to accurately identify the form of disease. Much of the treatment used is adapted from immunocompetent populations. Recent genomic and translational medicine advances have led to specific treatments. As chronic lung disease has continued to affect patients with PAD, we hope that continued advancements in our understanding of pulmonary pathology will ultimately lead to effective methods that alleviate impact on quality of life and survival.Entities:
Keywords: Asthma; Bronchiectasis; Common variable immunodeficiency; GLILD; Interstitial lung disease; Lung disease; Primary antibody deficiency
Mesh:
Substances:
Year: 2020 PMID: 32654691 PMCID: PMC7366316 DOI: 10.1016/j.iac.2020.03.003
Source DB: PubMed Journal: Immunol Allergy Clin North Am ISSN: 0889-8561 Impact factor: 3.479